| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3133 | |||||||||||||||||||||||
| Submitter : | Dr. Mark Buettner | Date & Time: | 12/14/2006 01:12:12 | |||||||||||||||||||||
| Organization : | Dr. Mark Buettner | |||||||||||||||||||||||
| Category : | Health Professional | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| Please refrain from using aborted fetal cell lines in the production of any and all vaccines. | ||||||||||||||||||||||||